EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Epigenetic reprogramming in cadmium-associated liver injury: Evidence, mechanistic insights, and therapeutic perspectives

Xing Zhang, Na Liu, Jie Zhou

Environmental Toxicology and Pharmacology · 2026

DOI: 10.1016/j.etap.2026.105178 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Environmental Toxicology and Pharmacology, 2026. Verfasst von Xing Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, 710032, China. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Cadmium, Chemical and Drug Induced Liver Injury, Environmental Pollutants. Die Arbeit nennt 108 Literaturangaben. Gefördert von: Shaanxi Province Key Research and Development Projects.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic cadmium (Cd) exposure is associated with adverse liver outcomes, including metabolic dysfunction-associated steatotic liver disease (MASLD), inflammation, and fibrosis, yet the mechanisms underlying persistent hepatic injury remain incompletely resolved. This review critically examines population-based and experimental evidence for Cd-associated epigenetic alterations, focusing on DNA methylation, histone modifications, N6-methyladenosine (m6A) RNA modification, and non-coding RNA regulation, and evaluates the extent to which these changes represent epigenetic dysregulation or remodeling versus relatively durable and functionally consequential reprogramming. Evidence is interpreted according to study design and level of functional validation. Current findings support context-dependent, model-specific roles for selected epigenetic regulators, with functional convergence on metabolic dysfunction, oxidative stress, inflammation, cell-death pathways, and fibrogenic activation, rather than a unified causal epigenetic program in humans. We further discuss cross-layer interactions, cell-type heterogeneity, emerging preclinical intervention strategies, and translational barriers, highlighting the need for longitudinal human studies, cell-resolved multi-omics, and target-specific functional validation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticCadmiumChemical and Drug Induced Liver InjuryEnvironmental PollutantsHumansAnimalsDNA MethylationRNA MethylationRNA, UntranslatedAdenosineEpitranscriptome

Stichwörter der Autor:innen

CadmiumEpigenetic remodelingHepatotoxicityHistone lactylationN(6)-methyladenosineNon-coding RNA

Substanzen

CadmiumRNA, UntranslatedAdenosineEnvironmental Pollutants

Autor:innen und Institutionen

  • Department of Endocrinology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, 710032, China.
  • Department of Endocrinology, Xijing Hospital, The Fourth Military Medical University, Xi'an, Shaanxi, 710032, China. Electronic address: zhoujie@fmmu.edu.cn.

Förderung

  • Shaanxi Province Key Research and Development Projects

Zitieren

APA

Zhang, X., Liu, N., & Zhou, J. (2026). Epigenetic reprogramming in cadmium-associated liver injury: Evidence, mechanistic insights, and therapeutic perspectives. Environmental Toxicology and Pharmacology. https://doi.org/10.1016/j.etap.2026.105178

Vancouver

Zhang X, Liu N, Zhou J. Epigenetic reprogramming in cadmium-associated liver injury: Evidence, mechanistic insights, and therapeutic perspectives. Environmental Toxicology and Pharmacology. 2026. doi:10.1016/j.etap.2026.105178

BibTeX
@article{Zhang2026,
  author = {Zhang, Xing and Liu, Na and Zhou, Jie},
  title = {Epigenetic reprogramming in cadmium-associated liver injury: Evidence, mechanistic insights, and therapeutic perspectives},
  journal = {Environmental Toxicology and Pharmacology},
  year = {2026},
  doi = {10.1016/j.etap.2026.105178}
}
Kostenlos starten →